Brooks Laboratories Ltd
NSE: BROOKS BSE: 533543
₹77.66
(1.32%)
Wed, 25 Feb 2026, 11:04 pm
Market Cap2.16B
PE Ratio10.59
Dividend0
Company History
2002
- Incorporation of Brooks Laboratories Limited.
- Received certificate for commencement of business.
2005
- Commenced setting up of manufacturing facility at Baddi, Himachal Pradesh.
- Commissioning of R&D centre at Baddi.
2006
- Manufacturing drugs license was issued by the State Drugs Controlling and Licensing Authority, HP.
- Completion of Commissioning of plant for manufacture of Tablets, capsules, Injections, Oral Liquids etc.
- Start of commercial production.
- First PPI Formulation was developed by the Company.
- Obtained Import license from Drugs Controller General of India under the Drugs Act 1940 and Drugs Rules.
2007
- Received an AS/NZS ISO 9001:2000 Certificate from SAI Global Certification Services Pty Limited, Australia.
2008
- Takeover of some of the Assets of M/s Brooks Pharmaceuticals by our Company.
- Dissolution of M/s Brooks Pharmaceuticals, a partnership firm of Our Promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan.
- Our Company paid/settled some dues to Creditors and Lenders of Brooks Pharmaceuticals aggregating to Rs. 151.79 Lacs.
2009
- Micro Small Medium Enterprise (MSME) Registration Certificate was issued by Directorate of Industries for Manufacturing/Assembling Injections, Capsules & Tabulates.
2010
- The manufacturing facility at Baddi was certified as WHO GMP compliant by Department of Health & Family Welfare, HP.
- Received an ISO 9001:2008 Certificate from UKAS Quality Management, URS & IAF.
2012
- The Registered Office of the Company was shifted to Village Kishanpura, Nalagarh Road, Baddi, Distt. Solan, H.P.
2013
- Mr. Bhaskar Sharma was appointed as Additional Independent Director of the company.
2014
- Ms. Sonia Gupta was appointed as Independent Director of the Company.
2015
- Brooks Laboratories shifted its Corporate Office to 5th Floor, Next to Hotel Courtyard Marriott, Andheri Kurla Road, Mumbai - 400093.
2016
- Brooks Laboratories gets manufacturing licence for Gujarat facility.
2023
- The company issued rights shares of Rs. 10 in the ratio of 1:16 at a premium of Rs. 65 per share.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800